Bausch + Lomb launched two preservative-free lubricating eye drops, Blink Nourish and Blink Boost, in the U.S., according to ...

The prevalence and severity of refractive and corneal astigmatism in children rose after the COVID-19 pandemic, according to ...

Congress passing the controversial One Big Beautiful Bill Act could leave millions without insurance and lead to at least ...

Universal presumption of low-dose aspirin, instead of risk-based screenings, can increase uptake for preeclampsia prevention ...

CHICAGO — Counties in the U.S. with the highest environmental burden, such as increased pollution, had significantly higher ...

International medical graduate hematology/oncology fellows demonstrate greater research productivity than American medical ...

At the Heart in Diabetes CME Conference, speakers highlighted four recent reports published in the Journal of the American ...

Adults with unresectable stage III or IV melanoma maintained similar progression-free disease control with 1- or 2-year ...

Among adults with chronic rhinosinusitis with nasal polyps who endured endoscopic sinus surgery, those with severe vs. mild ...

In this video, Susana M. Campos, MD, MPH, discusses results from a phase 2 trial of pembrolizumab and lenvatinib for patients with recurrent or persistent clear-cell ovarian cancer.Findings from the ...

In this video, Susana M. Campos, MD, MPH, discusses new data from the TRUST trial, which were presented at ASCO Annual Meeting.The trial compared primary cytoreductive surgery followed by chemotherapy ...

Relacorilant (Corcept Therapeutics), an investigational selective glucocorticoid receptor antagonist, in combination with nab-paclitaxel demonstrated PFS and OS benefit compared with nab-paclitaxel ...